Related Experiment Video
Updated: Mar 21, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic
1a Department of Heart Disease , Haukeland University Hospital , Bergen , Norway.
Insights
Left ventricular hypertrophy (LVH), a complication of hypertension, significantly elevates the risk of heart failure and sudden cardiac death. Understanding LVH is crucial for managing hypertensive heart disease.
Area of Science:
- Cardiology
- Hypertension Research
Background:
- Left ventricular hypertrophy (LVH) is a significant complication of hypertension, indicative of hypertensive heart disease.
- LVH markedly increases patient risk for severe cardiovascular events, including sudden cardiac death, stroke, myocardial infarction, and heart failure.
Purpose of the Study:
- To provide a clinical update on left ventricular hypertrophy (LVH) in the context of hypertension.
- To address the evolving epidemiology and clinical considerations of LVH.
Main Methods:
- Review of recent advancements in diagnostic tools for LVH.
- Analysis of demographic shifts in hypertensive populations.
- Expert commentary on modifying factors in LVH and myocardial dysfunction.
Main Results:
- Epidemiology of LVH has evolved due to new diagnostic technologies and changing demographics.
- Individualized LVH presentation is influenced by comorbidities, risk factors, and molecular pathways.
- Systolic and diastolic myocardial dysfunction are key aspects of LVH.
Conclusions:
- LVH in hypertension requires ongoing clinical attention and updated management strategies.
- The interplay of risk factors and molecular mechanisms is critical in LVH pathophysiology.
- Early detection and understanding of LVH are vital for preventing cardiovascular events.
Introduction:
Left ventricular hypertrophy (LVH) is a common complication to hypertension, indicating the presence of hypertensive heart disease, which puts the patient at a very high risk for subsequent clinical cardiovascular events like sudden cardiac death, stroke, myocardial infarction and heart failure.
Areas Covered:
The epidemiology of LVH has changed in recent years as a consequence of the development of new diagnostic tools and demographic changes in hypertensive populations. Expert commentary: In individual hypertensive patients, the presence and type of LVH and associated systolic and diastolic myocardial dysfunction is modified by the co-presence of other cardiovascular risk factors and comorbidities and as well as activation of the reninangiotensin-aldosterone system and other molecular mechanisms involved in LVH pathophysiology. The purpose of this review is to give a clinical update on LVH in hypertension.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Pathophysiology of Heart Failure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis I: Introduction

